Viking Therapeutics, Inc. (VKTX): A Bull Case Theory

We came across a bullish thesis on Viking Therapeutics, Inc. on Alpha Talon Investment Research’s Substack by AT Investment Research. In this article, we will summarize the bulls’ thesis on VKTX. Viking Therapeutics, Inc.'s share was trading at $36.15 as of December 15th. Rio Tinto's CEO Announces Plan to Generate Up to $10 Billion Through Divestments & Other Strategies Copyright: dolgachov / 123RF Stock Photo Viking Therapeutics is a clinical-stage biotechnology company focused on metabolic and endocri ...